Introduction
Ruthenium arene complexes have emerged in the last years as promising alternatives to the traditional platinum-based drugs in the frame of chemotherapy [1e4] . In general, ruthenium complexes seem to induce less side effects than platinum drugs, having different modes of action and being many times also active against metastases [1e4] . Two main families of these organometallic compounds bearing {Ru(h 6 -arene)} [2, 5] and {Ru(h 5 -cyclopentadienyl)} [6] scaffolds have been identified. All these organometallic compounds have a piano-stool structure, where three of the coordination sites are occupied by the (h 6 -arene) or the (h 5 -cyclopentadienyl) ligands, which serve to stabilize the Ru(II) centre. The three remaining coordination sites are occupied by several coligands that are able to modulate the cytotoxicity and stability of the compounds. The first family comprises the ruthenium(II)-arene RAPTA-type, [Ru(h 6 -arene)(PTA)X 2 ] (PTA ¼ 1,3,5-triaza-7-phosphaadamantane) and the RAED-type compounds, [Ru(h 6 -arene)(en)Cl] þ (en ¼ ethylenediamine) [5] . Several RAPTA compounds have revealed in vitro and in vivo anticancer activity and some of them show antimetastatic potential as well [5, 7] . The RAED compounds have shown important cytotoxicity against a wide panel of human cancer cell lines [8] and [Ru(h 6 -biphenyl)(en)Cl] þ showed in vivo reduction of the MCa mammary primary carcinoma and also on the development and growth of lung metastases [9] .
Relatively to the {Ru(h 5 -cyclopentadienyl)} family of com- [18] to good [13,17e19] cytotoxicity against several cancer cell lines. The RuCp family of complexes bearing heteroaromatic ligands is the most extensive one [6,20e29] . In this frame, we have selected the [RuCp(N,X)PPh 3 ] þ general structure (where N,X is a bidentate ligand coordinated by two nitrogen or a nitrogen and an oxygen atom) as the most promising scaffold in terms of cytotoxic properties and stability [6] . These compounds have showed excellent IC 50 values in several human cancer cell lines with different degrees of aggressiveness and also resistant to cisplatin (eg.: PC3, MCF7, MDAMB231, A2780, A2780CisR, HeLa, between others) [6] . Preliminary in vivo studies for a compound of this family, [RuCp(N,O)PPh 3 ] þ (N,O ¼ 2-benzoylpyridine) [21] , on nude mice bearing orthotopic triple negative breast cancer MDAMB231, proved the potential of these complexes by suppressing tumour growth comparatively to the controls and by inhibiting the formation of metastases [30] . These results undoubtedly show that further studies regarding these compounds should be undertaken. It is known that the incorporation of fluorine in bioactive molecules improve their pharmacological properties through the enhancement of metabolic stability, changes in their physicochemical properties or increasing binding affinities, resulting in an enhancement of their therapeutic efficacy [31, 32] . In the frame of cancer, 5-Fluoruacil (5-FU) has recognized tumour-inhibiting activity [33] . One of the best properties introduced by fluorine relies on the increased lipid solubility, which improves the rates of absorption and transport of drugs in vivo. Recently, compounds bearing perfluorinated chains coupled to ruthenium-p-cymene [34, 35] [37] . Taking these results into consideration we report here for the first time the synthesis of a bipyridine bearing two perfluorinated chains and the synthesis of the corresponding ruthenium-(h 5 -MeCp) complex. As far as we know these compounds are unexplored in the frame of anticancer agents.
Experimental section

General procedures
All reactions and manipulations were performed under nitrogen atmosphere using Schlenk techniques. All solvents used were dried and freshly distilled under nitrogen prior to use, using standard methods [38] . 1 The synthesis of Ru1 was adapted from Ref. [40] . To a stirred and degassed solution of hydrated ruthenium trichloride (0.5 g, 2.4 mmol) in ethanol (50 mL) was added triphenylphosphane (2.89 g, 11 mmol) and freshly distilled methylcyclopentadiene (5e6 mL). The dark brown mixture obtained was refluxed with vigorously stirring for 8 h until no more precipitation of the orange complex is observed. After refluxing, the mixture was cooled to room temperature overnight. The precipitate was filtered, washed with water (2 Â 20 mL), cold ethanol (2 Â 20 mL) and a mixture of ethanol and light petroleum ether (50:50 (%v/v), 2 Â 20 mL). The orange powder obtained was dried under vacuum originating Ru1 in moderate yield. Single crystals were isolated by recrystallization from dichloromethane/n-hexane.
Yield: 48%; orange powder, recrystallized from dichloromethane/n-hexane. Mp: ca. 145 C decomposition. 1 
X-ray crystal structure determination
The crystal of L1 was immersed in cryo-oil, mounted in a MiTeGen loop, and measured at 123 K on a Rigaku Oxford Diffraction Supernova using Cu Ka (l ¼ 1.54184 Å) radiation. The CrysAlisPro [41] program package was used for cell refinement and data reduction. A Gaussian absorption correction (CrysAlisPro [41] ) was applied to the intensities before structure solution. The structure was solved by charge flipping method using the SUPERFLIP [42] software. Structural refinement was carried out using SHELXL-2015 [43] . All H-atoms were positioned geometrically and constrained to ride on their parent atoms, with C-H ¼ 0.93e0.97 Å and U iso ¼ 1.2,U eq (parent atom).
Three-dimensional X-ray data for [RuCl(MeCp)(PPh 3 ) 2 ]$CH 2 Cl 2 (Ru1) were collected on a Bruker SMART Apex CCD diffractometer at 100(2) K, using a graphite monochromator and Mo-K a radiation (l ¼ 0.71073 Å) by the f-u scan method. Reflections were measured from a hemisphere of data collected of frames each covering 0.3 in u. A total of 76661 reflections were measured, all of which were corrected for Lorentz and polarization effects and for absorption by semi-empirical methods based on symmetry-equivalent and repeated reflections. Of the total, 6873 independent reflections exceeded the significance level jFj/s(jFj) > 4.0. After data collection, in each case a multi-scan absorption correction (SADABS) [44] was applied, and the structure was solved by direct methods and refined by full matrix least-squares on F 2 data using SHELX suite of programs [45] . The structure was solved by direct methods and refined by full-matrix least-squares methods on F 2 . The nonhydrogen atoms were refined with anisotropic thermal parameters in all cases. Hydrogen atoms were included in calculation positions and refined in the riding mode. A final difference Fourier map showed a residual density outside next to the chlorine atom of solvent molecule, which was not refined: Table 1 .
Electrochemical experiments
The cyclic voltammograms were obtained at room temperature using a EG&G Princeton Applied Research Potentiostat/Galvanostat Model 273A equipped with Electrochemical PowerSuite v2.51 software for electrochemical analysis, in anhydrous acetonitrile or dichloromethane with tetrabutylammonium hexafluorophosphate (0.1 and 0.2 M) as supporting electrolyte. The electrochemical cell was a homemade three electrode configuration cell with a platinum-disc working electrode (1.0 mm) probed by a Luggin capillary connected to a silver-wire pseudo-reference electrode and a platinum wire auxiliary electrode. All the potentials reported were measured against the ferrocene/ferrocenium redox couple as internal standard and normally quoted relative to SCE (using the ferrocenium/ferrocene redox couple E 1/2 ¼ 0.46 or 0.40 V versus SCE for dichloromethane or acetonitrile, respectively). All the experiments were performed in nitrogen atmosphere. Both the sample and the electrolyte (Fluka) were dried under vacuum for several hours prior to the experiment. Reagent grade solvents were dried, purified by standard procedures and distilled under nitrogen atmosphere before use.
Stability studies in DMSO and DMSO/DMEM
For the stability studies, all the complexes were dissolved in DMSO or 2% DMSO/98% DMEM at ca. 1 Â 10 À4 M for Ru1 and 8 Â 10 À5 M for Ru2 and their electronic spectra were recorded in the range allowed by the solvents at set time intervals.
Partition coefficient determination
The lipophilicity of Ru1 and Ru2 was measured by the shakeflask method [46] . The n-octanol and the aqueous phases were mutually saturated before the experiments, using analytical grade octanol and double distilled water. The samples were dissolved in octanol (stock solution: 1.15 Â 10 À4 M for Ru1 and 1.03 Â 10 À4 M for Ru2) and aliquots of the stock solution were equilibrated with water for 4 h in a mechanical shaker. The phase ratio was 2 mL/2 mL (n-octanol/water). After separation of the equilibrated phases (by centrifugation at 5000 rpm for 10 min) the concentration decrease of the solute was determined in the n-octanol phase by UVeVis spectrophotometry at the l max of each compound (355 nm for Ru1 and 419 nm for Ru2). Triplicate experiments have been performed for each complex. The concentration for each sample was determined using the calibration curve. The partition coefficients of Ru1 and Ru2 were calculated using the equation:
Cell lines and culture conditions
The noncancerous NCM460 cell line derived from normal colon epithelial mucosa, was obtained from INCELL's [47] , and the two colorectal cancer (CRC) derived cell lines, SW480 and RKO, were obtained from American Type Culture Collection (ATCC). All cell lines were maintained at 37 C under a humidified atmosphere containing 5% CO 2 . NCM460 and SW480 cells were grown in RPMI medium and RKO cells in DMEM, both supplemented with 10% FBS and 1% penicillin/streptomycin. Cells were subcultured once a week when 80% of confluence was reached and then seeded in sterile test plates for the assays.
Compounds dilution and storage
The Ru1 and Ru2 compounds were dissolved in DMSO. Aliquots were prepared and stored at À20 C, protected from light, and discharged after one month, by which time new samples were prepared.
Sulphorhodamine B (SRB) assay
RKO, SW480 and NMC460 cells were seeded at a concentration of 4 Â 10 4 cells/ml, 1 Â 10 5 cells/ml and 3 Â 10 5 cells/ml respectively, in 24-well test plates. After 24 h of seeding, cells were incubated with different concentrations of the Ru1 and Ru2 compounds during 48 h. For each cell line and compound, we performed two negative controls, a control (1) in which cells were incubated only with growth medium and another DMSO control (2) in which the cells were exposed to the concentration of DMSO in which the highest concentration of the compound was dissolved (maximum of 0.1% of DMSO per well (v/v)), to discard any influence of the DMSO in the results. After 48 h of treatment, cells were fixed in ice-cold methanol containing 1% acetic acid for at least 90 min at À20 C. Fixing solution was then removed and the plate was left air-dry at room temperature, then the fixed cells were incubated with 0.5% (w/v) SRB dissolved in 1% acetic acid for 90 min at 37 C protected from light. After washing with 1% acetic acid and air-drying at room temperature, SRB was solubilized with 10 mM Tris pH10. Absorbance was read at 540 nm in a microplate reader (SpectraMax 340PC Molecular Devices). Results were expressed relatively to the negative control 1, which was considered as 100% of cell growth. The results were obtained from at least three independent experiments, each experiment was done in triplicate.
The statistical analysis performed using one-way ANOVA test and the IC 50 were estimated using GraphPad Prism 6 software.
Colony formation assay
SW480 and RKO cell lines were seeded, at a concentration of 500 cells/ml and 300 cells/ml, respectively, in 6-well plates. After 24 h of seeding, cells were treated with ¼ IC 50 and IC 50 values of Ru2 and incubated for 48 h, when cells were washed with PBS and the medium was replaced with fresh medium. The negative control cells were treated with DMSO 0.1%. 5 days later, cells were washed with PBS and fixated with glutaraldehyde 6% (v/v) and crystal violet 0.5% (w/v) for three hours. Then, cells were washed with fresh water and the plate was left air dry. Colonies were counted using ImageJ 1.50i software. The results represent mean ± S.D. of at least three independent experiments. Statistical analysis was performed by one-way ANOVA with Turkey's multiple comparisons test. *P 0.05; **P 0.01; ***P 0.001 compared with negative control.
TUNEL assay
The cell lines SW480 and RKO were seeded, in 6-well plates, at a concentration of 2 Â 10 5 cells/ml and 8 Â 10 4 cells/ml, respectively. 24 h after seeding, cells were exposed to the IC 50 and 2 Â IC 50 values of Ru2. The negative control cells were treated with DMSO 0.1%. After 48 h, both floating and attached cells were collected and washed with PBS. To the resuspended pellet was added paraformaldehyde 4%, for 15 min at room temperature (RT), to fix the cells, which were then washed with PBS. Cytospins were performed using Cytospin 4 Cytocentrifuge (Thermo Fisher Scientific). Cells were then washed in PBS and permeabilized with ice-cold 0.1% Triton X-100 in 0.1% sodium citrate. TUNEL was performed using In Situ Cell Death Detection Kit, Fluorescein (Roche, Mannheim, Germany). Slides were mounted on Vectashield Mounting Medium with DAPI and maintained at À20 C until visualization in a fluorescence microscope (Leica DM 5000B, Leica Microsystems, Wetzlar, Germany). Values represent mean ± S.D. of at least three independent experiments. Statistical analysis was performed by one-way ANOVA with Turkey's multiple comparisons test. *P 0.05; **P 0.01; ***P 0.001; ****P 0.0001 compared with negative control.
Cell cycle analysis
RKO and SW480 cell lines were seeded at a concentration of 8 Â 10 4 cells/ml and 2 Â 10 5 cells/ml, respectively, in 6-well plates. (Table 2 ). This effect has been already observed for related compounds, where the bipyridine is substituted at the para-position (relatively to the nitrogen) [26] . In the case of Ru2 another intense band at 290 nm from the pep* electronic transitions occurring in the aromatic ring of L1 is observed. In the visible range, Ru2 presents an absorption band and a shoulder at 419 nm and~470 nm, respectively, that can be attributed to charge transfer transitions between the N,N-bidentate ligand L1 and the ruthenium centre ( Fig. 1) as observed in related complexes [19, 22, 25] . No significant modifications on band positioning were noticed in both solvents.
Complexes stability in aqueous solutions and estimation of lipophilicity
Envisaging the use of these new compounds as cytotoxic agents and their study in human cancer cell lines, their stability and behaviour in aqueous solution was studied in DMSO and in culture cellular media, using 2% DMSO, by UVeVis spectroscopy. DMSO is the co-solvent used in the biological assays in order to allow complete solubilization of the compounds. Ru1 spectral changes were about 25 and 10% at 24 h in DMSO and DMSO/DMEM, respectively, probably due to hydrolysis of the Ru-Cl bond (Fig. S1 ). Ru2 was found to be very stable with spectral changes lower than 6% over 24 h in both solutions (Fig. S2) .
The importance of hydrophobicity/lipophilicity of the compounds for medicinal purposes is a key feature in the development of new drugs since it affects their tissue permeability, binding to biomolecules, between others. In this frame, the n-octanol/water partition coefficient was measured using the shake-flask method, Fig. 2 . Molecular structure (top) and packing (bottom) of L1. Thermal ellipsoids are drawn at 50% probability level. at room temperature. It was not possible to get an exact value for Ru1 due to the spectral changes caused by the hydrolysis of the RuCl bond, however, analysis of the spectra in octanol showed that it has a lipophilic character, since all the compound remained in this fraction. Ru2 is also lipophilic (logP o/w ¼ 0.25; calibration curve in Fig. S3 ), as predictable by the known lipid solubility introduced by fluorine atoms. Single crystals of L1 were obtained by slow evaporation of chloroform at room temperature. Upon X-ray diffraction, it was revealed that the crystal of L1 belongs to the centrosymmetric triclinic space group P1. The asymmetric unit contains only half of the ligand molecule. The crystal packing shows intermolecular F/F (2.799e2.871 Å) interactions along with weak aliphatic CÀH/N (2.662 Å) hydrogen bonds (Fig. 2) . Table S1 contains selected bond lengths and angles for compound L1.
[Ru(MeCp)(PPh 3 ) 2 Cl]$CH 2 Cl 2 Ru1 crystallizes from dichloromethane solution as red blocks (crystal dimensions 0.30 Â 0.21 Â 0.18 mm). Fig. 3 shows an ORTEP representation of [Ru(MeCp)(PPh 3 ) 2 Cl] Ru1. The asymmetric unit contains for Ru1 one ruthenium complex and one CH 2 Cl 2 molecule. In the molecular structure, the ruthenium centre adopts a "piano stool" distribution formed by the ruthenium-MeCp unit bound to two phosphane ligands. One chloride ion occupies the other coordination position. X-ray structure analysis of Ru1 shows two enantiomers of the complex [Ru(MeCp)(PPh 3 ) 2 Cl] (Ru1) in the racemic crystal (space group P1), the chirality being due to a twist of the PPh 3 and Cp units. The complex [Ru(MeCp)(PPh 3 ) 2 Cl] (Ru1) presents a mirror plane which contain Cl, Ru and the centroid of Cp ring (see Fig. 4 ) [22, 48] . The distances for Ru-P bond are Ru(1)-P(1) ¼ 2.3132(6) Å and Ru(1)-P(2) ¼ 2.3204(6) Å. The distance between Ru and the centroid of the p-bonded cyclopentadienyl moiety is 1.842(30) Å to Ru centre (ring slippage 0.079 Å). The mean value of the Ru-C bond distance is 2.2048(2) Å. Table S2 contains selected bond lengths and angles for compound Ru1. 6 . Effects of Ru2 compounds on cell growth of NCM460 normal colon epithelial mucosa derived cell line and RKO and SW480 colorectal cancer derived cell lines, determined by SRB assay. The percentage of cell growth relatively to the negative control was determined after a period of 48 h of exposure to the compounds and is expressed as a mean ± SD for each treatment from at least three independent experiments. Statistical analyzes was performed by one-way ANOVA comparing all conditions with negative control. The results were statistically significant with values of p < 0.0001 (****) (n ¼ 3). was studied by cyclic voltammetry in dichloromethane and acetonitrile solutions, containing ammonium hexafluorophosphate as supporting electrolyte, between the limits imposed by the solvents (Table 2) . Complex Ru1 showed to be redox-active in both solvents, with ruthenium centered processes (oxidation) at 0.54 V (ACN) and 0.51 V (DCM) with i pc /i pa ratios of 0.7, suggesting some instability of the oxidized ruthenium species at the electrode surface. However, when the scan direction is immediately reverted after the oxidation potential, the processes became quasi-reversible (E 1/2 ¼ 0.50 V and E 1/2 ¼ 0.47 V for acetonitrile and dichloromethane, respectively). In dichloromethane, this ruthenium centered process is followed by two other irreversible oxidative processes, also found in similar compounds [25] , and probably originated by the oxidation of species resulting of the first Ru (Fig. 5) , complex Ru2 was characterized by a quasi-reversible ruthenium centered process at E 1/2 ¼ 0.83 V and an irreversible reduction at E pc ¼ À1.69 V, which can be attributed to a ligand-based process. The electrochemical response of Ru2 in dichloromethane is consistent with the behaviour observed in acetonitrile, with a quasi-reversible redox process at E 1/2 ¼ 0.855 V, found when the [25] in the same experimental conditions (Table 3 ), indicating that the substitution of the cyclopentadienyl ring by the electron donor methyl group influences the electronic capability of the ruthenium(II) centre, making easier the oxidation process.
In vitro cytotoxicity analysis and IC 50 determination
Colorectal cancer (CRC) derived cell lines RKO and SW480, as well as NCM460, a noncancerous cell line derived from normal colon epithelial cells, were incubated for 48 h with different concentrations of Ru1 and Ru2 compounds to assess cell growth by Sulphorhodamine B (SRB) assay. Compound L1 could not be tested since its solubility in cellular media (and DMSO) is very limited. Ru1 compound had no significant effect at the concentrations tested compared to the negative controls in the three cell lines (Fig. S3) . Ru2 proved to be a very active compound in colorectal cancer cell lines showing a significant decrease in cell growth even for low doses and not exhibiting a significant effect on the noncancerous cell line NCM460 that showed to be more resistant (Fig. 6 ). Ru2 compound affects the growth of these cells in values in the micromolar range. The half-maximal inhibitory concentration 
Proliferation and apoptosis analysis
In order to evaluate the clonogenic ability of Ru2 in RKO and SW480 a colony formation assay was performed using the ¼ IC 50 and IC 50 values. In both cell lines the Ru2 compound affected the ability to form colonies in a dose-dependent manner (Fig. 7) . Ru2, at a concentration of 2 mM (IC 50 ), inhibits the ability to produce colonies in the RKO cell line.
The cell cycle distribution was assessed by flow cytometry, after 48 h of exposure to the IC 50 and 2 Â IC 50 values for RKO and SW480. Two peaks corresponding to the G0/G1 and G2/M phases of the cell cycle were evident in DNA content histograms (Fig. 8) . Comparing with the negative control, the IC 50 value does not affect the cell cycle phases, in the RKO cell line. However, the 2 Â IC 50 value led to an increase in the percentage of cells in G0/G1 cell cycle phase and, consequently, an arrest at that phase. Relatively to the hypodiploid sub-G1 cell-cycle phase, only for RKO, the 2 Â IC 50 value showed an increase in the percentage of cells (5%) comparing with the negative control (1.5%). SW480 did not show significant differences between treatments compared to the negative control.
We also assessed the levels of late apoptosis by TUNEL assay, after an incubation for 48 h with IC 50 and 2 Â IC 50 values for both cell lines. In comparison to the negative control, there were significant increase in the number of TUNEL positive cells with 2 mM and 4 mM (0.7% vs. 7% and 11%) for RKO and 1.5 mM and 3 mM (0.5% vs. 3% and 5%) for SW480 (Fig. 9) . In both cell lines apoptotic bodies were observed, phenotypic alterations typical of apoptosis.
Our results suggest that Ru2 seems to have more effect in RKO than in SW480 cells, which could be related with the different genetic background of the cells.
Conclusions
A new bipyridine-perfluorinared ligand L1 and two ruthenium organometallic complexes, Ru1 and Ru2, were newly synthesized and characterized. L1 and Ru1 were also studied by single-crystal X-ray. Both compounds crystalize in the centrosymmetric triclinic space group P1. Ru1 and Ru2 cytotoxicity was evaluated in two human derived CRC cell lines, RKO and SW480, and in a noncancerous cell line, NCM460. While compound Ru1 was not cytotoxic for any of the tested cell lines, compound Ru2, [Ru(h Moreover, Ru2 could inhibit colony formation and induce apoptosis in CRC cell lines. Our results suggest that Ru2 show an intrinsic selectivity towards cancer cells in relation to the normal colon epithelial derived cells which is approximately 4 times more resistant to the Ru2 compound.
Overall, our results indicate that Ru2 seems a very promising candidate for future studies aiming at understanding its mechanism of action in order to investigate its potential use as a new anticancer agent to be used at least in colorectal cancer therapy strategies.
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